SLC5A2 and type 2 diabetes mellitus: Additionally, SGLT-2 or GLP-1s are recommended for patients with established or at high risk for atherosclerotic cardiovascular disease [40] and have been found to decrease mortality and cardiovascular disease in people with type 2 diabetes [40].